1. Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database. (August 2022) Authors: Rippel, Noa; Tremblay, Douglas; Zubizarreta, Nicole; Podoltsev, Nikolai; Gotlib, Jason; Heaney, Mark; Kuykendall, Andrew; O'Connell, Casey; Shammo, Jamile M.; Fleischman, Angela; Kremyanskaya, Marina; Hoffman, Ronald; Mesa, Ruben; Yacoub, Abdulraheem; Mascarenhas, John Journal: Leukemia research Issue: Volume 119(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy. (June 2020) Authors: Talati, Chetasi; Goldberg, Aaron D.; Przespolewski, Amanda; Chan, Onyee; Ali, Najla Al; Kim, Jongphil; Famulare, Chris; Sallman, David; Padron, Eric; Kuykendall, Andrew; Lancet, Jeffrey E.; Wang, Eunice; Tallman, Martin S.; Komrokji, Rami; Sweet, Kendra Journal: Leukemia research Issue: Volume 93(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera. Issue 6 (11th June 2022) Authors: Tremblay, Douglas; Srisuwananukorn, Andrew; Ronner, Lukas; Podoltsev, Nikolai; Gotlib, Jason; Heaney, Mark L.; Kuykendall, Andrew; O'Connell, Casey L.; Shammo, Jamile M.; Fleischman, Angela; Mesa, Ruben; Yacoub, Abdulraheem; Hoffman, Ronald; Moshier, Erin; Zubizarreta, Nicole; Mascarenhas, John Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of obesity on survival of patients with myelodysplastic syndromes. Issue 1 (1st January 2021) Authors: Schwabkey, Zaker; Al Ali, Najla; Sallman, David; Kuykendall, Andrew; Talati, Chetasi; Sweet, Kendra; Lancet, Jeffrey; Padron, Eric; Komrokji, Rami Journal: Hematology Issue: Volume 26:Issue 1(2021) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy. (October 2021) Authors: Hunter, Anthony M.; Al Ali, Najla; Mai, Anne; Shah, Savan; Swoboda, David M.; Kuykendall, Andrew; Talati, Chetasi; Sweet, Kendra L.; Sallman, David A.; Lancet, Jeffrey E.; Komrokji, Rami S.; Padron, Eric Journal: Leukemia research Issue: Volume 109(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023) Authors: Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kilad... Journal: Lancet Issue: Volume 401:Issue 10373(2023) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database. (October 2021) Authors: Tremblay, Douglas; Ronner, Lukas; Podoltsev, Nikolai; Gotlib, Jason; Heaney, Mark; Kuykendall, Andrew; O'Connell, Casey; Shammo, Jamile M.; Fleischman, Angela; Mesa, Ruben; Yacoub, Abdulraheem; Hoffman, Ronald; Moshier, Erin; Zubizarreta, Nicole; Mascarenhas, John Journal: Leukemia research Issue: Volume 109(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy‐related myelodysplastic syndromes. (24th June 2022) Authors: Volpe, Virginia O.; Al Ali, Najla; Chan, Onyee; Padron, Eric; Sallman, David A.; Kuykendall, Andrew; Sweet, Kendra; Lancet, Jeffrey E.; Komrokji, Rami S. Journal: British journal of haematology Issue: Volume 198:Number 4(2022) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis. Issue 1 (2nd January 2022) Authors: Komrokji, Rami; Melody, Megan; al Ali, Najla; Chan, Onyee; Klimek, Virginia; Ball, Brian J.; Sekeres, Mikkael A.; Lucas, George; Maciejewski, Jaroslaw P.; Sallman, David A.; Padron, Eric; Kuykendall, Andrew; Lasho, Terra; Al-Kali, Aref; Naqvi, Kiran; Steensma, David P.; Garcia-Manero, Guillermo; ... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗